Metrizamide computed tomography cisternography: pediatric applications.
The methodology and clinical use of metrizamide (Amipaque) computed tomography (CT) cisternography are described as applied in the cases of 22 children with morphologic and physiologic abnormalities affecting the cranial portion portion of the central nervous system. In contrast to pneumoencephalography, CT cisternography affords equivalent or superior visualization of the basal cranal subarachnoid spaces with simpler technique and low morbidity. Intrathecal metrizamide enchancement in children causes a very low incidence of side effects.
D000238:Adenoma, Chromophobe / Q000000981:diagnostic imaging; D000293:Adolescent; D001927:Brain Diseases / Q000000981:diagnostic imaging*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging; D001933:Brain Stem; D002648:Child; D002675:Child, Preschool; D003287:Contrast Media; D003560:Cysts / Q000000981:diagnostic imaging; D004678:Encephalomalacia / Q000000981:diagnostic imaging; D005910:Glioma / Q000000981:diagnostic imaging; D006801:Humans; D006849:Hydrocephalus / Q000000981:diagnostic imaging; D007223:Infant; D007278:Injections, Spinal; D007463:Iodobenzoates / Q000008:administration & dosage*; D008793:Metrizamide / Q000008:administration & dosage* / Q000009:adverse effects; D009192:Myelography; D014057:Tomography, X-Ray Computed
D003287:Contrast Media; D007463:Iodobenzoates; D008793:Metrizamide